ULURU INC. ANNOUNCES EXTENSIVE CLINICAL EVIDENCE PRESENTED AT THE 24TH ANNUAL "CLINICAL SYMPOSIUM ON ADVANCES IN SKIN AND WOUND CARE"

  • Symposium to Feature 16 Poster Presentations on the Clinical Results of Altrazeal™
Addison, Texas, October 21, 2009; ULURU Inc. (NYSE Alternext: ULU) today announced that there will be 16 poster presentations featuring clinical and pharmacoeconomic results at the 24th Annual “Clinical Symposium on Advances in Skin and Wound Care” to be held in San Antonio, Texas from October 22-25. Read More
Become a fan at Facebook
Facebook Icon
Please follow me at Twitter
Twitter Icon